Home/Filings/4/0001193805-24-001491
4//SEC Filing

Chivukula Pad 4

Accession 0001193805-24-001491

CIK 0001768224other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:06 PM ET

Size

5.8 KB

Accession

0001193805-24-001491

Insider Transaction Report

Form 4
Period: 2024-12-16
Chivukula Pad
Chief Scientific Officer & COO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-12-16+60,00060,000 total
    Exercise: $16.24Exp: 2034-12-16Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
  • [F2]The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.

Issuer

Arcturus Therapeutics Holdings Inc.

CIK 0001768224

Entity typeother

Related Parties

1
  • filerCIK 0001727317

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:06 PM ET
Size
5.8 KB